Sernova Corp.
http://www.sernova.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sernova Corp.
Deal Watch: Innoviva To Buy The Rest Of Entasis For Enterprise Value Of $113m
Bookmark
-
News
Already owner of about 60% of the troubled antibiotic firm, Innoviva agrees to pay $2.20 per share for all outstanding stock in Entasis. Roche, KaliVir partner on oncolytic virus therapies.
Moving Cell And Gene Therapies Into Chronic Conditions Depends On Durability, Safety
Bookmark
-
Analysis
Biopharma executives discussed their strategies for treating chronic diseases during the Cell and Gene Meeting on the Mesa, including R&D and regulatory considerations.
Company Information
Advertisement
Advertisement